Search research articles
Contact Us
Filters
Showing results (31-40 of 180) with videos related to
Page
of 18
Sort By:
Proceedings of the National Academy of Sciences of the United States of America
|
February 26, 2004
The BRCA1-associated protein BACH1 is a DNA helicase targeted by clinically relevant inactivating mutations
Sharon Cantor, Ronny Drapkin, Fan Zhang, et al.
The American Journal of Surgical Pathology
|
April 27, 2007
Distinctive cytogenetic profile in benign metastasizing leiomyoma: pathogenetic implications
Marisa R Nucci, Ronny Drapkin, Paola Dal Cin, et al.
Gynecologic Oncology
|
November 6, 2025
The 15th Biennial Rivkin Center ovarian cancer research symposium
Kenneth P Nephew, Ronny Drapkin, Jackie Lang, et al.
Frontiers in Bioscience (Elite Edition)
|
January 4, 2011
STICS, SCOUTs and p53 signatures; a new language for pelvic serous carcinogenesis
Karishma Mehra, Mitra Mehrad, Geng Ning, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 7, 2015
Creation of a Human Secretome: A Novel Composite Library of Human Secreted Proteins: Validation Using Ovarian Cancer Gene Expression Data and a Virtual Secretome Array
Vinod Vathipadiekal, Victoria Wang, Wei Wei, et al.
Current Opinion in Obstetrics & Gynecology
|
January 16, 2007
The distal fallopian tube: a new model for pelvic serous carcinogenesis
Christopher P Crum, Ronny Drapkin, Alexander Miron, et al.
Gynecologic Oncology
|
June 21, 2011
Stathmin 1, a marker of PI3K pathway activation and regulator of microtubule dynamics, is expressed in early pelvic serous carcinomas
Alison M Karst, Keren Levanon, Sekhar Duraisamy, et al.
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists
|
December 25, 2007
Serous carcinogenesis in the fallopian tube: a descriptive classification
Elke Jarboe, Ann Folkins, Marisa R Nucci, et al.
The American Journal of Surgical Pathology
|
April 24, 2010
PAX8 reliably distinguishes ovarian serous tumors from malignant mesothelioma
Anna R Laury, Jason L Hornick, Ruth Perets, et al.
Gynecologic Oncology
|
September 1, 2015
Beyond genomics: critical evaluation of cell line utility for ovarian cancer research
Kevin M Elias, Megan M Emori, Eniko Papp, et al.
Page
of 18
Search research articles
Search
Showing results (31-40 of 180) with videos related to
Sort By:
Page
of 18
Proceedings of the National Academy of Sciences of the United States of America
|
February 26, 2004
The BRCA1-associated protein BACH1 is a DNA helicase targeted by clinically relevant inactivating mutations
Sharon Cantor, Ronny Drapkin, Fan Zhang, et al.
The American Journal of Surgical Pathology
|
April 27, 2007
Distinctive cytogenetic profile in benign metastasizing leiomyoma: pathogenetic implications
Marisa R Nucci, Ronny Drapkin, Paola Dal Cin, et al.
Gynecologic Oncology
|
November 6, 2025
The 15th Biennial Rivkin Center ovarian cancer research symposium
Kenneth P Nephew, Ronny Drapkin, Jackie Lang, et al.
Frontiers in Bioscience (Elite Edition)
|
January 4, 2011
STICS, SCOUTs and p53 signatures; a new language for pelvic serous carcinogenesis
Karishma Mehra, Mitra Mehrad, Geng Ning, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 7, 2015
Creation of a Human Secretome: A Novel Composite Library of Human Secreted Proteins: Validation Using Ovarian Cancer Gene Expression Data and a Virtual Secretome Array
Vinod Vathipadiekal, Victoria Wang, Wei Wei, et al.
Current Opinion in Obstetrics & Gynecology
|
January 16, 2007
The distal fallopian tube: a new model for pelvic serous carcinogenesis
Christopher P Crum, Ronny Drapkin, Alexander Miron, et al.
Gynecologic Oncology
|
June 21, 2011
Stathmin 1, a marker of PI3K pathway activation and regulator of microtubule dynamics, is expressed in early pelvic serous carcinomas
Alison M Karst, Keren Levanon, Sekhar Duraisamy, et al.
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists
|
December 25, 2007
Serous carcinogenesis in the fallopian tube: a descriptive classification
Elke Jarboe, Ann Folkins, Marisa R Nucci, et al.
The American Journal of Surgical Pathology
|
April 24, 2010
PAX8 reliably distinguishes ovarian serous tumors from malignant mesothelioma
Anna R Laury, Jason L Hornick, Ruth Perets, et al.
Gynecologic Oncology
|
September 1, 2015
Beyond genomics: critical evaluation of cell line utility for ovarian cancer research
Kevin M Elias, Megan M Emori, Eniko Papp, et al.
Page
of 18